Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NUWE

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
01/13/20257:00AMGlobeNewswire Inc.Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® TherapyNASDAQ:NUWENewellis Inc
12/19/20248:00AMGlobeNewswire Inc.Nuwellis Regains Compliance with Nasdaq Listing RequirementsNASDAQ:NUWENewellis Inc
11/20/202412:29PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NUWENewellis Inc
11/11/20247:00AMGlobeNewswire Inc.Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent HighlightsNASDAQ:NUWENewellis Inc
11/11/20245:04AMIH Market NewsTesla Rises 5% Pre-Market After Surpassing $1T Market Value; U.S. Bans TSMC From Selling Advanced Chips to ChinaNASDAQ:NUWENewellis Inc
11/05/20248:28AMGlobeNewswire Inc.Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross ProceedsNASDAQ:NUWENewellis Inc
11/04/20247:30AMGlobeNewswire Inc.Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and MedicaidNASDAQ:NUWENewellis Inc
11/01/20243:15PMGlobeNewswire Inc.Nuwellis Announces Preliminary Results for Third Quarter of 2024NASDAQ:NUWENewellis Inc
10/31/20247:00AMGlobeNewswire Inc.Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric CustomerNASDAQ:NUWENewellis Inc
10/23/20243:15PMGlobeNewswire Inc.Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:NUWENewellis Inc
09/25/20243:15PMGlobeNewswire Inc.Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities ConferenceNASDAQ:NUWENewellis Inc
08/30/20243:11PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NUWENewellis Inc
08/27/20248:00AMGlobeNewswire Inc.New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
08/26/20243:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
08/23/20248:31PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NUWENewellis Inc
08/23/20248:00AMGlobeNewswire Inc.Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:NUWENewellis Inc
08/13/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
08/13/202412:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
08/13/20247:00AMGlobeNewswire Inc.Nuwellis, Inc. Announces Second Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
08/12/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
08/08/20248:00AMGlobeNewswire Inc.Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to ConditionsNASDAQ:NUWENewellis Inc
08/02/20243:12PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NUWENewellis Inc
08/02/20242:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NUWENewellis Inc
07/26/20248:00AMGlobeNewswire Inc.Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’sNASDAQ:NUWENewellis Inc
07/25/20248:25AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NUWENewellis Inc
07/25/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
07/24/20247:02AMGlobeNewswire Inc.Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:NUWENewellis Inc
07/23/20243:10PMGlobeNewswire Inc.Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024NASDAQ:NUWENewellis Inc
07/17/20243:01PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
07/17/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE